Tiansheng Pharmaceutical Group Co Ltd (002872) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.011x

Based on the latest financial reports, Tiansheng Pharmaceutical Group Co Ltd (002872) has a cash flow conversion efficiency ratio of -0.011x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-22.57 Million ≈ $-3.30 Million USD) by net assets (CN¥1.97 Billion ≈ $288.25 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Tiansheng Pharmaceutical Group Co Ltd (002872) total market value for the company's overall valuation and market capitalisation.

Tiansheng Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how Tiansheng Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Tiansheng Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tiansheng Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency. Explore Tiansheng Pharmaceutical Group Co Ltd cash earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Aurion Resources Ltd V:AU	-0.009x
Leonteq AG SW:LEON	0.774x
GBank Financial Holdings Inc. Common Stock NASDAQ:GBFH	-0.058x
Teraplast Bist RO:TRP	0.028x
Syntec Optics Holdings Inc. NASDAQ:OPTX	-0.004x
NN Inc NASDAQ:NNBR	0.142x
Changzhou Tiansheng New Materials Co Ltd SHE:300169	0.028x
COG Financial Services Ltd AU:COG	0.198x

Annual Cash Flow Conversion Efficiency for Tiansheng Pharmaceutical Group Co Ltd (2012–2024)

The table below shows the annual cash flow conversion efficiency of Tiansheng Pharmaceutical Group Co Ltd from 2012 to 2024. View 002872 live share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥2.01 Billion ≈ $294.76 Million	CN¥50.15 Million ≈ $7.34 Million	0.025x	+312.41%
2023-12-31	CN¥2.10 Billion ≈ $306.66 Million	CN¥-24.56 Million ≈ $-3.59 Million	-0.012x	-128.75%
2022-12-31	CN¥2.19 Billion ≈ $320.11 Million	CN¥89.18 Million ≈ $13.05 Million	0.041x	+389.79%
2021-12-31	CN¥2.28 Billion ≈ $333.52 Million	CN¥18.97 Million ≈ $2.78 Million	0.008x	-89.52%
2020-12-31	CN¥2.39 Billion ≈ $349.69 Million	CN¥189.75 Million ≈ $27.77 Million	0.079x	+62.67%
2019-12-31	CN¥2.95 Billion ≈ $432.30 Million	CN¥144.21 Million ≈ $21.10 Million	0.049x	+0.86%
2018-12-31	CN¥3.18 Billion ≈ $465.60 Million	CN¥153.99 Million ≈ $22.53 Million	0.048x	+376.86%
2017-12-31	CN¥3.19 Billion ≈ $466.69 Million	CN¥-55.75 Million ≈ $-8.16 Million	-0.017x	-106.41%
2016-12-31	CN¥1.86 Billion ≈ $272.02 Million	CN¥506.68 Million ≈ $74.14 Million	0.273x	+107.92%
2015-12-31	CN¥1.63 Billion ≈ $238.37 Million	CN¥213.54 Million ≈ $31.25 Million	0.131x	-2.29%
2014-12-31	CN¥1.43 Billion ≈ $209.40 Million	CN¥191.99 Million ≈ $28.09 Million	0.134x	+153.41%
2013-12-31	CN¥1.08 Billion ≈ $157.71 Million	CN¥57.06 Million ≈ $8.35 Million	0.053x	-65.27%
2012-12-31	CN¥951.66 Million ≈ $139.26 Million	CN¥145.06 Million ≈ $21.23 Million	0.152x	--

About Tiansheng Pharmaceutical Group Co Ltd

SHE:002872 China Biotechnology

Market Cap

$273.62 Million

CN¥1.87 Billion CNY

Market Cap Rank

#15349 Global

#4528 in China

Share Price

CN¥5.88

Change (1 day)

-1.01%

52-Week Range

CN¥4.47 - CN¥6.09

All Time High

CN¥32.59